Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEDESTAL: Peginterferon Lambda-1a vs Alfa-2a in HCV GT1
NCT01598090Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2012
- Primary completion
- Feb 2015
- Modality
- Cytokines & Interferons
- Countries
- 15
01
Overview
A Phase 3 trial of peginterferon lambda-1a in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Jun 2012; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01598090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01598090.